Literature DB >> 3396073

The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements.

C K Glass1, J M Holloway, O V Devary, M G Rosenfeld.   

Abstract

We report that the thyroid hormone (T3) receptor binds to DNA recognition sequences that are variations of the palindromic motif 5'-TCAGGTCA.TGACCTGA-3', resulting in transcriptional activation in vivo. This sequence is identical to the vitellogenin A2 estrogen response element except for the absence of 3 bp at the center of dyad symmetry, which we have termed a "gap." The T3 receptor binds to estrogen response elements with high affinity in vitro, as well as to variations of the same sequence containing gaps of 1-6 bp. The T3 receptor not only fails to activate transcription from estrogen response elements in vivo, but inhibits estrogen-dependent transactivation. We propose that the T3 receptor binds to estrogen response elements in a transcriptionally inactive form and competes for estrogen receptor binding, resulting in a net decrease in gene expression. These data reveal that only a subset of T3 receptor DNA-binding elements function as T3 response elements.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3396073     DOI: 10.1016/0092-8674(88)90194-8

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  156 in total

1.  In vivo transcription factor recruitment during thyroid hormone receptor-mediated activation.

Authors:  M K Kim; J S Lee; J H Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

2.  Accumulation of different c-erbA transcripts during rat brain development and in cortical neurons cultured in a synthetic medium.

Authors:  D Castiglia; A Cestelli; C Di Liegro; L Bonfanti; I Di Liegro
Journal:  Cell Mol Neurobiol       Date:  1992-06       Impact factor: 5.046

3.  Thyroid hormone receptor transcriptional activity is potentially autoregulated by truncated forms of the receptor.

Authors:  J Bigler; W Hokanson; R N Eisenman
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

4.  A negative retinoic acid response element in the rat oxytocin promoter restricts transcriptional stimulation by heterologous transactivation domains.

Authors:  S M Lipkin; C A Nelson; C K Glass; M G Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

Review 5.  Nuclear thyroid hormone receptors.

Authors:  M A Lazar; W W Chin
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

6.  Molecular cloning of the mammalian fatty acid synthase gene and identification of the promoter region.

Authors:  C M Amy; B Williams-Ahlf; J Naggert; S Smith
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

7.  The C'-terminal interaction domain of the thyroid hormone receptor confers the ability of the DNA site to dictate positive or negative transcriptional activity.

Authors:  J M Holloway; C K Glass; S Adler; C A Nelson; M G Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

8.  Mutations that define the optimal half-site for binding yeast GCN4 activator protein and identify an ATF/CREB-like repressor that recognizes similar DNA sites.

Authors:  J W Sellers; A C Vincent; K Struhl
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

9.  H-2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility class I genes and the estrogen response element.

Authors:  K Hamada; S L Gleason; B Z Levi; S Hirschfeld; E Appella; K Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

10.  Novel mechanism of positive versus negative regulation by thyroid hormone receptor β1 (TRβ1) identified by genome-wide profiling of binding sites in mouse liver.

Authors:  Preeti Ramadoss; Brian J Abraham; Linus Tsai; Yiming Zhou; Ricardo H Costa-e-Sousa; Felix Ye; Martin Bilban; Keji Zhao; Anthony N Hollenberg
Journal:  J Biol Chem       Date:  2013-11-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.